Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 7Lymphoma, Follicular 6Leukemia, Biphenotypic, Acute 6Leukemia 6Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Burkitt Lymphoma 3Prostatic Neoplasms 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Multiple Myeloma 2Lymphohistiocytosis, Hemophagocytic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Epstein-Barr Virus Infections 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumocystis 1Pneumonia 1Pain 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Large-Cell, Anaplastic 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Prednisone 53Radiotherapy 52Docetaxel 51Leuprolide 48Goserelin 47bicalutamide 45enzalutamide 28acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27Androgen Antagonists 27Flutamide 24Triptorelin Pamoate 22apalutamide 18Gonadotropin-Releasing Hormone 18Abiraterone Acetate 17Radiation 15abiraterone 14Zoledronic Acid 14Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 12Prednisolone 11luprolide acetate gel depot 10darolutamide 9Radiosurgery 9cabazitaxel 8Standard of Care 8Specimen Handling 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Estramustine 8Dexamethasone 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × Methylprednisolone × Clear all
NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

GU Research Network, LLC

Phase 3 Completed
2 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

UNICANCER

Phase 3 Terminated
160 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡